Barchart.com
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Opko Health Inc (OPK)

Opko Health Inc (OPK)
1.4350 +0.0250 (+1.77%) 15:00 ET [NASDAQ]
1.4300 x 1355 1.4400 x 2556
Realtime by (Cboe BZX)
1.4300 x 1355 1.4400 x 2556
Realtime 1.4559 +0.0409 (+2.89%) 09:14 ET
News & Headlines for Mon, Apr 14th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program GlobeNewswire - Fri Apr 4, 7:00AM CDT

OPK : 1.4350 (+1.41%)
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders GlobeNewswire - Mon Mar 17, 7:00AM CDT

OPK : 1.4350 (+1.41%)
ENTX : 1.6700 (-1.18%)
Opko Health (OPK) Q4 2024 Earnings Call Transcript Motley Fool - Thu Feb 27, 9:45PM CST

OPK earnings call for the period ending December 31, 2024.

OPK : 1.4350 (+1.41%)
OPKO Health: Q4 Earnings Snapshot AP - Thu Feb 27, 5:15PM CST

OPKO Health: Q4 Earnings Snapshot

OPK : 1.4350 (+1.41%)
OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results GlobeNewswire - Thu Feb 27, 3:10PM CST

OPK : 1.4350 (+1.41%)
OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025 GlobeNewswire - Thu Feb 13, 3:05PM CST

OPK : 1.4350 (+1.41%)
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire - Thu Jan 9, 10:45AM CST

OPK : 1.4350 (+1.41%)
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck GlobeNewswire - Tue Jan 7, 7:00AM CST

OPK : 1.4350 (+1.41%)
Author
3 Stocks That Wall Street Insiders Can’t Stop Buying MarketBeat - Mon Dec 30, 2024

Insider trades are a telling indicator of C-Suite conviction but aren't always the signal for investors they could be. Only two of these stocks are good buys.

VSTS : 7.90 (+0.38%)
GEF : 52.67 (+1.37%)
OPK : 1.4350 (+1.41%)
CTAS : 210.15 (+1.99%)
UNF : 175.28 (+0.65%)
Insider Purchase: CEO & Chairman of $OPK (OPK) Buys 500,000 Shares Quiver Quantitative, Inc. - Thu Dec 12, 2024

PHILLIP MD ET AL FROST, the CEO & Chairman of $OPK ($OPK), bought 500,000 shares of the company on 12-11-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

OPK : 1.4350 (+1.41%)

Barchart Exclusives

Cotton Prices Have Bottomed, But Fundamentals Need to Improve for a Sustained Price Uptrend Barchart - 3 minutes ago
Get ready for a likely summertime rally in cotton futures prices. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
UTC
Reserve Your Spot